FIELD: medicine.
SUBSTANCE: therapeutic agent contains recombinant interferon specified in a group of: recombinant interferon alpha, recombinant interferon beta, recombinant interferon gamma, metronidazole, fluconazole and/or voriconazole, and a pharmaceutically acceptable base in the following proportions, g per 1 ml of the mixture: recombinant interferon, international units 100-10,000,000; metronidazole 0.00001-0.5; fluconazole and/or voriconazole 0.00001-0.5; pharmaceutically acceptable base - the rest. Besides, the therapeutic agent contains boric acid in an amount of 0.00001-0.5 g and hypromellose in an amount of 0.00001-0.5 g. As a pharmaceutically acceptable base, it contains macrogol 400 or macrogol 1500, or macrogol 4000.
EFFECT: higher efficacy of the compound.
2 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECOSIS, POSSESSING ANTIPARASITIC, ANTIBACTERIAL, ANTIVIRAL, IMMUNOMODULATORY ACTION | 2013 |
|
RU2538710C1 |
JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 |
|
RU2533274C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING INDIVIDUALS SUFFERING XEROSTOMIA | 2013 |
|
RU2538699C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING TROPHIC ULCERS AND PERSISTENT WOUNDS OF VARIOUS ORIGINS IN FORM OF OINTMENT | 2013 |
|
RU2539383C1 |
PHARMACEUTICAL COMPOSITION FOR IMMEDIATE TREATMENT OF BURNS OF VARIOUS ORIGINS, AREA AND DEPTH IN FORM OF SPRAY, GEL AND AEROSOL | 2014 |
|
RU2545798C1 |
GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
CYTOKINE-CONTAINING MEDICATION, POSSESSING ANTIVIRAL, ANTIMICROBIAL, IMMUNOMODULATING AND ANTI-INFLAMMATORY ACTION FOR PREVENTION AND TREATMENT OF INFECTION DISEASES | 2013 |
|
RU2554495C2 |
DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 |
|
RU2488405C1 |
MEDICINAL FOR VAGINAL APPLICATION, WITH ANTIVIRAL, ANTIMICROBIAL, ANTIFUNGAL, ANTIPROTOZOAL, ANTIINFECTIOUS, IMMUNOMODULATING AND ANTIINFLAMMATORY ACTION, AS OINTMENT, GEL, SUPPOSITORY | 2016 |
|
RU2633056C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF PAPILLOMATOSIS OF VARIOUS LOCALISATION | 2013 |
|
RU2537232C1 |
Authors
Dates
2015-03-10—Published
2013-11-29—Filed